Betty Zhang
Subscribe to Betty Zhang's PostsBetty (Yajing) Zhang focuses her practice on antitrust and other regulatory matters. Read Betty (Yajing) Zhang's full bio.
States Want in on the Merger Review Fun
By Jon B. Dubrow, Elai Katz and Betty Zhang on Aug 8, 2024
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Joint Ventures/Competitor Collaboration, Mergers & Acquisitions
WHAT HAPPENED While they have long taken a back seat to federal merger reviews, US states are becoming increasingly involved in merger reviews, including potentially requiring premerger notifications on a broad scale. On July 24, 2024, the Uniform Law Commission adopted its Uniform Antitrust Pre-Merger Notification Act (Model Act) as model legislation for states to...
Continue Reading
How Orange Book Antitrust Scrutiny Is Intensifying
By Elai Katz, Lisa P. Rumin and Betty Zhang on Aug 1, 2024
Posted In FTC Developments, Healthcare Antitrust, IP Antitrust, Monopolization/Abuse of Dominance
Pharmaceutical patent holders beware: Over the past year, antitrust enforcers have taken a more aggressive approach challenging Orange Book listings as an anticompetitive practice. According to the Federal Trade Commission, improperly listing patents in the Orange Book constitutes an unfair method of competition, among other violations. In this article, Elai Katz, Lisa Rumin and Betty...
Continue Reading
What California’s DOJ Said at the 2024 Antitrust Law Section Spring Meeting
By Michelle Lowery, Betty Zhang, Russell Hayman, Jon Dean, Julian Andre, Maria Rodriguez and Yesenia Gallegos on Apr 29, 2024
Posted In DOJ Developments, FTC Developments, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting earlier this month featured federal, state and international enforcers discussing a variety of antitrust and competition issues across jurisdictions. Paula Blizzard, the California Department of Justice’s antitrust chief, provided insights into the California attorney general office’s current and upcoming enforcement activities. Read more here.
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part II
By Lisa P. Rumin, Anthony S. Ferrara, Reese Poncia, Noah Feldman Greene, Zachary Sproull, Han Cui, Graham Hyman, Glenna Siegel, Alex Grayson, Betty Zhang and Gregory E. Heltzer on Apr 12, 2024
Posted In Agriculture, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting concluded on April 12. The annual Spring Meeting featured updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight takeaways from the final two days of the Spring Meeting. Read more here.
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Anthony S. Ferrara, Claire Danberg, Glenna Siegel, Bailey K. Sanders, Betty Zhang and Alex Grayson on Apr 11, 2024
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting is underway in Washington, DC. The annual Spring Meeting features updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight the key takeaways from the first portion of the Spring Meeting. Read...
Continue Reading
